Scoop: Biotech de­vel­op­ing oral Alzheimer's drug is on $50M hunt

A biotech at­tempt­ing to de­vel­op an oral drug for pa­tients with Alzheimer’s dis­ease is cur­rent­ly rais­ing a Se­ries E.

The drug de­vel­op­er, Alzheon, dis­closed a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER